Sign up for the QMED & MD+DI Daily newsletter.
Advisory Panel Green Lights Heart Device
A device that freezes part of the heart in order to stop abnormal heart rhythms has been recommended for approval by an FDA advisory panel, the Associated Press reports. The Cardiac Cryoablation System from Cryocor Corp. (San Diego) uses a catheter to send nitrous oxide into part of the heart. The nitrous oxide freezes tissues and creates lesions in the upper chamber that ablate areas responsible for the abnormal rhythms.
Smart Artificial Urinary Sphincter Advances Bid for FDA ApprovalFeb 23, 2024|5 Min Read
Sustainable Manufacturing Expo Hits North AmericaFeb 22, 2024|4 Min Read
Medtronic Doubles Down on Sustainability EffortsFeb 22, 2024|1 Min Read
Top Medical Device M&AFeb 21, 2024|1 Min Read